CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated March 7, 2024 relating to the financial statements of Foghorn Therapeutics Inc. appearing in the Annual Report on Form 10-K of Foghorn Therapeutics Inc. for the year ended December 31, 2023.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
May 6, 2024
